Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
The interest cost savings may not be enough to entice some countries to accept the European Stability Mechanism’s pandemic crisis loans, with Portuguese and Cypriot officials expressing doubt. -
Travelodge has opted to restructure its debts through a CVA rather than using the UK’s new restructuring framework, shortly to become law. That means landlords are likely to be the losers, rather than bondholders.
-
The coronavirus pandemic may have inadvertently solved one of the longest-running complaints about Europe’s equity capital markets: the time it takes to do an IPO. And many in the market hope this is a permanent change, write Sam Kerr and Aidan Gregory.
-
A $5bn take-private of Spanish telecoms operator MasMovil is the first sign of the return of M&A deal-making. But as bankers work frantically behind the scenes to rebuild the market, the big, integrated houses look set to dominate, writes David Rothnie.
-
Engie, the French electricity and gas company, braved the markets alone as the European Central Bank met on Thursday, with the bigger than expected fresh wave of bond buying announced forecast to keep the rally in corporate credit going.
-
Kion, the German crossover-rated forklift truck maker, has signed a €1bn crisis funding facility, becoming the latest company to turn to KfW’s loan scheme to get through the coronavirus pandemic.
